Silica exposure and systemic vasculitis.

PubWeight™: 0.89‹?›

🔗 View Article (PMC 1241769)

Published in Environ Health Perspect on December 01, 2003

Authors

Karen B Mulloy1

Author Affiliations

1: Program in Occupational and Environmental Health, Department of Internal Medicine, University of New Mexico Health Sciences Center, University of New Mexico, Albuquerque 87131-0001, USA. kmulloy@salud.unm.edu

Articles cited by this

An epidemiological study of rheumatoid arthritis associated with characteristic chest x-ray appearances in coal-workers. Br Med J (1953) 10.93

Certain unusual radiological appearances in the chest of coal-miners suffering from rheumatoid arthritis. Thorax (1953) 9.41

Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis (2003) 2.40

End-stage renal disease among silica-exposed gold miners. A new method for assessing incidence among epidemiologic cohorts. JAMA (1997) 1.99

Occupational exposure to crystalline silica and autoimmune disease. Environ Health Perspect (1999) 1.95

Circulating antinuclear and rheumatoid factors in coal miners. A prevalence study in Pennsylvania and West Virginia. Ann Intern Med (1973) 1.76

ANCA-positive vasculitis. J Am Soc Nephrol (2002) 1.69

Silica exposure and autoimmune diseases. Am J Ind Med (1995) 1.59

High prevalence of antinuclear antibodies in sandblasters' silicosis. Am Rev Respir Dis (1976) 1.51

Occupational exposure to crystalline silica and risk of systemic lupus erythematosus: a population-based, case-control study in the southeastern United States. Arthritis Rheum (2002) 1.29

Silica exposure and rheumatoid arthritis: a follow up study of granite workers 1940-81. Br Med J (Clin Res Ed) (1987) 1.27

Evidence for the role of environmental agents in the initiation or progression of autoimmune conditions. Environ Health Perspect (1999) 1.26

Epidemiology of the vasculitides. Rheum Dis Clin North Am (2001) 1.26

Kidney disease and arthritis in a cohort study of workers exposed to silica. Epidemiology (2001) 1.23

Silica-associated connective tissue disease. A study of 24 cases. Medicine (Baltimore) (1995) 1.16

Association between silica exposure and necrotizing crescentic glomerulonephritis with p-ANCA and anti-MPO antibodies: a hospital-based case-control study. Adv Exp Med Biol (1993) 1.15

Soluble Fas mRNA is dominantly expressed in cases with silicosis. Immunology (1998) 1.12

Elevated soluble Fas/APO-1 (CD95) levels in silicosis patients without clinical symptoms of autoimmune diseases or malignant tumours. Clin Exp Immunol (1997) 1.10

Autoimmune diseases associated with drugs, chemicals and environmental factors. Toxicol Lett (2000) 1.08

The significance of irregular opacities on the chest roentgenogram. Chest (1992) 1.04

Silicon exposure and vasculitis. Curr Opin Rheumatol (1998) 1.04

Epidemiologic studies of environmental agents and systemic autoimmune diseases. Environ Health Perspect (1999) 1.04

New developments in pathogenesis of systemic vasculitis. Curr Opin Rheumatol (1998) 1.03

Serum levels of soluble Fas ligand in patients with silicosis. Clin Exp Immunol (1999) 1.01

ANCA-associated small-vessel vasculitis. Am Fam Physician (2002) 1.01

Silica, silicosis, and progressive systemic sclerosis. Br J Ind Med (1985) 0.98

Classification and epidemiology of the vasculitides. Baillieres Clin Rheumatol (1997) 0.98

Relationship between silicosis and rheumatoid arthritis. Thorax (1986) 0.97

Diffuse interstitial fibrosis in nonasbestos pneumoconiosis--a pathological study. Respiration (1993) 0.95

ANCA-associated diseases and silica exposure. Clin Rev Allergy Immunol (1997) 0.91

15. Vasculitis. J Allergy Clin Immunol (2003) 0.90

Vasculitis associated with primary rheumatologic diseases. Curr Opin Rheumatol (1998) 0.84

Mechanisms and genetics of autoimmunity. Ann N Y Acad Sci (1998) 0.83

Introduction to immunology and autoimmunity. Environ Health Perspect (1999) 0.81

Radiologic and pathologic characteristics of mixed dust pneumoconiosis. Radiographics (1996) 0.77

Systemic sclerosis (scleroderma) in two iron ore mines. Occup Med (Lond) (1999) 0.77